China Shijiazhuang Pharmaceutical Group Optimizes Supply Chain Operations Wit bi13281748 Global supply chain optimization provider Manhattan Associates, Inc. (Nasdaq:MANH) today announced that China Shijiazhuang Group (CSPC), a large enterprise specializing science, technology and trading, implementing Manhattan Associates' Warehouse Management solution (WMS) at new distribution center (DC) Shijiazhuang, China

Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date bi13281748 WEIFANG, China, Dec. 9, 2011 /PRNewswire-Asia-FirstCall/ -- Shengtai , Inc. (OTC Bulletin Board: SGTI) (''Shengtai'' or ''the Company'' or "we" or "us"), a manufacturer and distributor China of glucose and starch as raw materials and other starch and..

Aoxing Pharmaceutical Company Announces $3.2 Million Financing bi13281748 JERSEY CITY, N.J., Dec. 7, 2011 /PRNewswire/ -- Aoxing (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty company focusing on research, development, manufacturing and distribution of narcotic, pain-management, and addiction treatment s, today..

Stellar to Acquire Tribute Pharmaceuticals to Create Premier North American S bi13281748 LONDON, ONTARIO and MILTON, ONTARIO-- - Stellar s Inc. and privately held Tribute s announced today that Stellar has acquired 100% of the outstanding shares of Tribute s ..

Unity Management Group, Inc. Receives Contract From Sun Pharmaceutical India' bi13281748 EAST HANOVER, N.J., Dec. 6, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTCMARKETS: UYMG) "UNITY" (or the "Company"), and subsidiary, Metropolitan Computing Corporation (MCC) are pleased to announce the receipt of an order from Sun . The contract is..

CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy to Board of Directors bi13281748 BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (?CorMedix?) (NYSE Amex: CRMD), a company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced the appointment of Matthew Duffy to Board of Directors. Mr. Duffy has extensive experience includes early stage product ..

K-V Pharmaceutical Company Comments on Recent Settlement With the Department bi13281748 ST. LOUIS, Dec. 7, 2011 /PRNewswire/ -- K-V Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today commented on the settlement of false claims allegations the U.S. Department of Justice ("DOJ") associated the Company's former ETHEX generic..

China Shijiazhuang Pharmaceutical Group Optimizes Supply Chain Operations Wit bi13281748 Global supply chain optimization provider Manhattan Associates, Inc. (Nasdaq:MANH) today announced that China Shijiazhuang Group (CSPC), a large enterprise specializing science, technology and trading, implementing Manhattan Associates' Warehouse Management solution (WMS) at new distribution center (DC) Shijiazhuang, China

Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date bi13281748 WEIFANG, China, Dec. 9, 2011 /PRNewswire-Asia-FirstCall/ -- Shengtai , Inc. (OTC Bulletin Board: SGTI) (''Shengtai'' or ''the Company'' or "we" or "us"), a manufacturer and distributor China of glucose and starch as raw materials and other starch and..

Aoxing Pharmaceutical Company Announces $3.2 Million Financing bi13281748 JERSEY CITY, N.J., Dec. 7, 2011 /PRNewswire/ -- Aoxing (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty company focusing on research, development, manufacturing and distribution of narcotic, pain-management, and addiction treatment s, today..

Stellar to Acquire Tribute Pharmaceuticals to Create Premier North American S bi13281748 LONDON, ONTARIO and MILTON, ONTARIO-- - Stellar s Inc. and privately held Tribute s announced today that Stellar has acquired 100% of the outstanding shares of Tribute s ..

Unity Management Group, Inc. Receives Contract From Sun Pharmaceutical India' bi13281748 EAST HANOVER, N.J., Dec. 6, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTCMARKETS: UYMG) "UNITY" (or the "Company"), and subsidiary, Metropolitan Computing Corporation (MCC) are pleased to announce the receipt of an order from Sun . The contract is..

CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy to Board of Directors bi13281748 BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (?CorMedix?) (NYSE Amex: CRMD), a company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced the appointment of Matthew Duffy to Board of Directors. Mr. Duffy has extensive experience includes early stage product ..

Tapeware Backup Software - Home